J McKendrick

Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial

Werner Scheithauer, J McKendrick, S. Begbie et al. · Annals of Oncology · 2003 · 272 citations · Full text

Gastrointestinal Oncology, Oral Capecitabine, Medicine +8

First-line bevacizumab combined with reduced dose interferon-α2a is active in patients with metastatic renal cell carcinoma

Bohuslav Melichar, P. Koralewski, Alain Ravaud et al. · Annals of Oncology · 2008 · 103 citations · Full text

Urology, Reduced Dose Interferon-α2a, First-line Bevacizumab +6

Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield

Tara Seshadri, Debra A. Gook, Stephen Lade et al. · British Journal of Cancer · 2006 · 96 citations · Full text

Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation

Andrew Spencer, Noemi Horvath, John Gibson et al. · Bone Marrow Transplantation · 2005 · 68 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +10

Results From VELOUR, a Phase 3 Study of Aflibercept (A) Versus Placebo (pbo) in Combination with FOLFIRI for the Treatment of Patients (pt) with Previously Treated Metastatic Colorectal Cancer (MCRC)

Josep Tabernero, Eric Van Cutsem, Radek Lakomý et al. · European Journal of Cancer · 2011 · 33 citations

Gastrointestinal Oncology, Medicine, Cancer Management +10